Dutch media attack “chilling” fines for slimming drugs coverage

Dutch media outlets have faced substantial fines from the health department's inspectorate for their coverage of weight loss drugs such as Ozempic, Wegovy, and Mounjaro. The fines, issued by the inspectorate IGJ, have amounted to tens of millions of euros and are being perceived as an attack on press freedom by editors. These fines were issued due to the positive reporting on the benefits of these drugs beyond treating diabetes, which is the only condition they are officially prescribed for in the Netherlands.

The Dutch Medicines Act prohibits advertising for prescription medicines. The IGJ has issued around 20 fines for breaching this law since 2023, including fines to major media companies like DPG Media, Mediahuis, and Telegraaf. Journalists' union NVJ expressed shock over the fines and called for talks with the health ministry to discuss the sanctions, saying it makes reporting on health issues impossible.

Media executives, including editors from Volkskrant and Telegraaf, have also criticized the fines, calling it a "chilling effect" on journalism and an infringement of press freedom.